Skip to content

Influence of Peer Mentoring on Adolescent Contraceptive Decision Making

The Influence of Peer Mentoring on Contraceptive Decision Making Among Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02157285
Acronym
ImPACCT
Enrollment
110
Registered
2014-06-05
Start date
2013-02-28
Completion date
2013-10-31
Last updated
2014-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LARC Desire, Peer Counseling

Keywords

Unintended pregnancy in adolescence, LARC, contraception

Brief summary

This is a prospective, randomized-controlled trial in which subjects will be randomized to receive either routine contraceptive counseling or peer mentoring plus routine contraceptive counseling.

Detailed description

Unintended adolescent pregnancy continues to be a significant public health problem in the United States. While the use of highly effective forms of birth control, such as the long-acting, reversible contraceptives (LARC) have been found to be more effective in decreasing pregnancy rates than non-LARC methods of birth control, knowledge and use of LARC has been shown to be low in this vulnerable population. We are interested in better understanding the influence peers may have on contraceptive decision making among adolescents. The purpose of this study is to evaluate the impact of a peer mentoring intervention on adolescent contraceptive decision making, specifically with regard to increasing long-acting, reversible contraceptive uptake. The main study intervention will consist of randomization to usual contraceptive counseling versus peer-mentoring plus usual contraceptive counseling. Pre- and post-intervention questionnaires will be used to better understand peer influence on contraceptive decision making, and to assess the peer mentor-teen intervention interaction.

Interventions

BEHAVIORALPeer Mentor Counseling

Peer mentoring will entail the peer mentor describing her positive experience with her LARC method. The participant will then have a chance to ask any experience related questions to the mentor. Any clinical inquiries or questions the mentor does not feel comfortable answering, she will defer to the contraceptive counselor/ physician who will be subsequently providing the routine counseling. The entire peer mentor encounter should not last more than 10 minutes.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking * Female * Age 13-21 years old at enrollment * Desiring contraception; either currently not taking any method of contraception, or not satisfied with current method, and not desiring pregnancy in the next 12 months * Willing and able to follow the study protocol

Exclusion criteria

* Male gender * Younger than 13 years old, older than 21 years old * Pregnant or desiring pregnancy within the coming year * Issues or concerns in the judgement of the investigator that may compromise the safety of the subject or confound the reliability of compliance and information acquired in this study

Design outcomes

Primary

MeasureTime frameDescription
Number of study participants who chose long-acting reversible contraception (LARC) after all contraceptive counseling was done.at enrollment/baseline visitThis data was obtained by the number of participants who chose to have an IUD or Implant inserted after counseling at their clinic visit.

Secondary

MeasureTime frameDescription
Number of participants who maintained LARC uptake4 months from enrollment/baseline visitThis data is being obtained through a brief follow-up questionnaire conducted over the phone.
Number of participants who maintained a positive opinion of LARC method as their primary choice for birth control4 months after enrollment/baseline visit.This data is being obtained through a brief follow-up questionnaire conducted over the phone.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026